TE Connectivity acquires three life science development and manufacturing firms; expands reach into IVD, point of care and microfluidics segments

TE Connectivity, a world leader in connectors and sensors, has acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research and manufacturing. The companies are Toolbox Medical Innovations (USA), Wi Inc (USA) and microiLIQUID (Spain).

The combined entities leverage design and manufacturing capabilities in the United States and Europe and are focused on serving a global client base ranging from startups to multinationals in the life science, IVD and cell therapy markets.

A “Horizon Strategy” Framework for Science and Technology Policy

The current U.S. innovation model has in multiple respects fallen short in the face of today’s technology competition challenges. MITRE calls for a national-level effort between government, industry, and academia to address the most critical S&T priorities.

WashU Experts: The first 100 Biden/Harris days

Obamacare will get retooled, not repealed. A national mask mandate will boost consumer spending, research shows (though don’t expect much from homeowners, they’re strapped). The $300 billion for R&D should go to D, not R. So forecasts an array of WashU experts.

National Virtual Biotechnology Laboratory Symposium, October 28

A virtual symposium to highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory (NVBL) has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19, and to discuss areas in which the NVBL can have impact in the future. The event is aimed at the S&T community, media, and the general public.

Tackling COVID-19 with Optimism and Ingenuity

Joe Stetter is an optimist, inventor, entrepreneur, and owner of two small businesses that stayed open through the lockdown. KWJ Engineering and Spec Sensors manufacture essential health and safety sensors with medical and industrial applications. In our series, The ECS Community Adapts and Advances, Joe shares the challenges of doing business “not as usual”, and reports on a research collaboration he mobilized to improve PPE sterilization for COVID-19 frontline workers.

What If People Use Autonomous Vehicles To Do Bad Things?

There’s a fairly large flaw in the way that programmers are currently addressing ethical concerns related to artificial intelligence and autonomous vehicles (AVs). Namely, existing approaches don’t account for the fact that people might try to use the AVs to do something bad.

‘Artificial Chemist’ Combines AI, Robotics to Conduct Autonomous R&D

Researchers have developed a technology called “Artificial Chemist,” which incorporates artificial intelligence and an automated system for performing chemical reactions to accelerate R&D and manufacturing of commercially desirable materials.